Disclosure of interest: Ismail Ismail: nothing to disclose, Abdel Douiri: nothing to disclose, Yanzhong Wang: nothing to disclose, Charles Wolfe: nothing to disclose, Ajay Bhalla: nothing to disclose, Eva Emmett: nothing to disclose, Matthew DL OConnell: nothing to disclose, Iain Marshall: nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2483 - ESOC25-657 RELATIONSHIP BETWEEN LIPOPROTEIN(a) LEVELS AND INTRACRANIAL STENOSIS: INSIGHTS FROM A SINGLE CENTER RETROSPECTIVE STUDY Matteo Paolucci 1 , Giacomo Urbinati 1 , Mauro Gentile 1 , Stefano Forlivesi 1 , Giorgia Arnone 1 , Mario Sebastiani 1 , Andrea Zini 1 1 IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurology and Stroke Centre, Maggiore Hospital, Bologna, Italy Background and Aims: Lipoprotein(a) [Lp(a)] has emerged as an independent cardiovascular risk factor, with its role in intracranial atherosclerotic stenosis (ICAS) under increasing scrutiny

Originally identified in human plasma, GHK-Cu is composed of the amino acid sequence glycyl-L-histidyl-L-lysine bound to copper ions
Its especially beneficial for: Busy professionals who need fast recovery from fatigue, stress, or long days
In another 12-week facial study of 67 women between 50 and 59 years with mild to advanced photodamage, a GHK-Cu cream was applied twice daily and improved skin laxity, clarity, firmness and appearance, reduced fine lines, coarse wrinkles and mottled pigmentation, and increased skin density, and thickness
Warfarin: The effects of warfarin and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone
D., & Cunningham, F